These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
379 related items for PubMed ID: 19261873
41. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease. Geerts H, Grossberg GT. J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810 [Abstract] [Full Text] [Related]
42. Modulation of NMDA receptor function by ketamine and magnesium: Part I. Liu HT, Hollmann MW, Liu WH, Hoenemann CW, Durieux ME. Anesth Analg; 2001 May; 92(5):1173-81. PubMed ID: 11323343 [Abstract] [Full Text] [Related]
43. Pharmacological and Electrophysiological Characterization of Novel NMDA Receptor Antagonists. Leiva R, Phillips MB, Turcu AL, Gratacòs-Batlle E, León-García L, Sureda FX, Soto D, Johnson JW, Vázquez S. ACS Chem Neurosci; 2018 Nov 21; 9(11):2722-2730. PubMed ID: 29767953 [Abstract] [Full Text] [Related]
44. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors. Bettini E, Sava A, Griffante C, Carignani C, Buson A, Capelli AM, Negri M, Andreetta F, Senar-Sancho SA, Guiral L, Cardullo F. J Pharmacol Exp Ther; 2010 Dec 21; 335(3):636-44. PubMed ID: 20810618 [Abstract] [Full Text] [Related]
45. Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors. Bettini E, Stahl SM, De Martin S, Mattarei A, Sgrignani J, Carignani C, Nola S, Locatelli P, Pappagallo M, Inturrisi CE, Bifari F, Cavalli A, Alimonti A, Pani L, Fava M, Traversa S, Folli F, Manfredi PL. Pharmaceuticals (Basel); 2022 Aug 13; 15(8):. PubMed ID: 36015145 [Abstract] [Full Text] [Related]
46. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons. Aracava Y, Pereira EF, Maelicke A, Albuquerque EX. J Pharmacol Exp Ther; 2005 Mar 13; 312(3):1195-205. PubMed ID: 15522999 [Abstract] [Full Text] [Related]
49. [Role of magnesium ions on the regulation of NMDA receptor--a pharmacopathology of memantine]. Kato T. Clin Calcium; 2004 Aug 13; 14(8):76-80. PubMed ID: 15577101 [Abstract] [Full Text] [Related]
58. Alzheimer's disease and the glutamate NMDA receptor. Doraiswamy PM. Psychopharmacol Bull; 2003 Dec 13; 37(2):41-9. PubMed ID: 14566213 [Abstract] [Full Text] [Related]
59. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Chen HS, Wang YF, Rayudu PV, Edgecomb P, Neill JC, Segal MM, Lipton SA, Jensen FE. Neuroscience; 1998 Oct 13; 86(4):1121-32. PubMed ID: 9697119 [Abstract] [Full Text] [Related]
60. Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization. Parsons CG, Danysz W, Bartmann A, Spielmanns P, Frankiewicz T, Hesselink M, Eilbacher B, Quack G. Neuropharmacology; 1999 Jan 13; 38(1):85-108. PubMed ID: 10193901 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]